Page 24 - பல்கலைக்கழகம் ஆஃப் பென்சில்வேனியா பெரல்மேன் பள்ளி மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பல்கலைக்கழகம் ஆஃப் பென்சில்வேனியா பெரல்மேன் பள்ளி மருந்து. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பல்கலைக்கழகம் ஆஃப் பென்சில்வேனியா பெரல்மேன் பள்ளி மருந்து Today - Breaking & Trending Today

'Race Correction' May Lead to Underdiagnosis of Lung Disease

How a well-meaning U.S. government database fuels dangerous vaccine misinformation


How a well-meaning U.S. government database fuels dangerous vaccine misinformation
By
Melissa Goldin, John Gregory, and Kendrick McDonald
On 5/25/21 at 12:01 AM EDT
Anna Shvets/Pexels
On April 30, 2021, the website Natural News which NewsGuard has rated Red, meaning generally unreliable published a story reporting the death of a 2-year-old who in late February had received the second dose of a Pfizer-BioNTech COVID-19 vaccine during the companies clinical trials for children. The only problem? Children under 5 did not begin receiving shots until April, according to a press releaseon the Pfizer website.
Natural News picked up the false claim from a familiar source of pandemic misinformation: Red-rated website Great Game India, which in January 2020 also spread a different falsehood that the COVID-19 virus was stolen from a Canadian lab. ....

United States , United Kingdom , University Of Pennsylvania , Joseph Mercola , Christian Elliot , Kristen Nordlund , Walter Orenstein , Tom Shimabukuro , Barbara Loe Fisher , James Laidler , Susan Ellenberg , Shaydanay Urbani , Paul Offit , Mehdi Benkebil , Robertf Kennedy Jr , Ludwig Bailey , Anna Rosa Marra , Harvard Pilgrim Health Care , Us Congress , Us Centers For Disease , Children Health Defense , Emory School Of Medicine , National Childhood Vaccine Injury Act , European Union , Immunization Safety Office , University Of Pennsylvania Perelman School Medicine ,

Corbus Pharmaceuticals Announces Publication of Two


Corbus Pharmaceuticals Announces Publication of Two Abstracts at EULAR 2021 Virtual Congress
Corbus Pharmaceuticals Holdings, Inc.
Norwood, Massachusetts, UNITED STATES
Norwood, MA, May 25, 2021 (GLOBE NEWSWIRE) Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced the publication of two abstracts at the European League Against Rheumatism (EULAR) 2021 Virtual Congress that will be taking place June 2-5, 2021.
Details of the presentations are as follows:
Presentation Title
: Phase 3 Trial of Lenabasum, a CB2 Agonist, for the Treatment of Diffuse Cutaneous Systemic Sclerosis (dcSSc)
Session: Progress in myositis and scleroderma research - I ....

Lindsey Smith , Ted Jenkins , Robert Spiera , University Of Pennsylvania Perelman School Medicine , Corbus Pharmaceuticals Holdings Inc , Weill Cornell Medical College , Peuropean League Against Rheumatism , Exchange Commission , Corbus Pharmaceuticals Contacts , Corporate Communications , Securities Exchange , Virtual Congress , Myositis Program , Pharmaceuticals Holdings , Diffuse Cutaneous Systemic Sclerosis , Special Surgery , Co Principal Investigator , Corbu Phase , Long Term Safety , Open Label Extension , Refractory Skin Disease , Victoria Werth , Pennsylvania Perelman School , Scientific Conferences , Securities Act , Securities Exchange Act ,